CMS fast-tracks breakthrough device coverage + shipping hits
Supply Chain Pulse — 2026-04-24
CMS and FDA just launched their RAPID Coverage Pathway, promising to cut breakthrough device approval timelines by involving Medicare in clinical trial design from day one. It's the biggest shake-up in device reimbursement strategy in years, arriving just as shipping costs spike 23 cents per pound on UPS routes and Iran tensions threaten global supply chains. If you've been waiting for regulatory clarity on innovative devices while juggling rising logistics costs, today's developments demand immediate attention to your procurement roadmaps.
Quick Hits
- Abbott cuts profit forecast following Exact Sciences acquisition deal (Modern Healthcare)
- Cumberland Pharmaceuticals selling drug portfolio to Apotex for $100M (Pharmaceutical Business Review)
- Siemens Healthineers Americas chief pushes deeper provider partnerships (Modern Healthcare)
- Employers ramp up healthcare lobbying as benefit costs spike nationwide (Modern Healthcare)
CMS, FDA launch RAPID pathway to fast-track breakthrough device coverage
The new program embeds CMS staff directly in clinical trial design for breakthrough devices, potentially shaving months off traditional coverage decisions. For supply chain leaders, this means earlier visibility into which innovative devices will get Medicare reimbursement, enabling more strategic capital planning. The pilot could fundamentally change how you evaluate and time breakthrough device acquisitions.
Ocean shipping surcharges hit as Iran conflict threatens Strait of Hormuz
Closure risks at the Strait of Hormuz are driving up oil prices and triggering new shipping surcharges just as contract negotiations heat up. Medical device and pharmaceutical shipments from Asia could see significant cost increases if tensions escalate further. Supply chain teams should review alternative routing options and consider accelerating critical inventory builds.
Source: Supply Chain Dive - Healthcare
UPS adds 23-cent surge fee to all US international shipments
The temporary surcharge applies across seven UPS services for shipments between the US and most other countries, with no end date announced. For hospitals relying on international suppliers for specialized devices or pharmaceuticals, this represents an immediate cost increase that could affect thousands of shipments monthly. Time to review your logistics contracts and carrier mix.
Source: Supply Chain Dive - Healthcare
Philips scores FDA clearance for new Rembra scanning platform
The 510(k) clearance covers CT, RT, and Areta RT systems in Philips' latest imaging portfolio. For imaging directors planning capital refreshes, this represents a significant new option with potentially different service, training, and integration requirements than legacy systems. Expect competitive pricing pressure on existing CT contracts as Philips pushes market entry.
Source: Medical Device Network
Hospital price transparency gains traction with employers
Employer groups report meaningful progress from price transparency rules, citing better visibility into hospital, insurer, and PBM pricing practices. This growing employer sophistication could pressure hospitals to justify supply costs more rigorously, especially for high-cost devices and pharmaceuticals. Expect more granular cost reporting requests from commercial payers.
CMS proposes ending easy breakthrough device payment boosts
While launching the RAPID pathway, CMS simultaneously wants to eliminate current processes that help breakthrough devices secure supplemental Medicare payments. The mixed signals suggest a more rigorous approach to device reimbursement ahead, where speed comes with stricter cost-effectiveness standards. Device manufacturers may need to build stronger economic cases from day one.
Health systems race to scale hospital-at-home before reimbursement shifts
Providers are aggressively expanding hospital-at-home programs to secure more state and Medicare Advantage coverage before potential policy changes. This creates immediate demand for home monitoring devices, mobile diagnostics, and specialized medical supplies that traditional hospitals don't typically stock. Supply chain teams should evaluate partnerships with home healthcare distributors now.
You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe